Ameriprise
STJ

Ameriprise’s St Jude Medical STJ Stock Holding History

Ameriprise’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-13,200
Closed -$1.05M – 4011
2016
Q3 		$1.05M Buy
+13,200
New +$1.07M ﹤0.01% 2893

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Ameriprise's STJ Position: Q1 2017 in Review

Ameriprise sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 661,216 shares — an estimated $53M sold.

Ameriprise first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $304M in Q2 2015. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Ameriprise reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Ameriprise sold 661,216 St Jude Medical shares in Q1 2017, an estimated $53M.
  • Ameriprise first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • Ameriprise's St Jude Medical position peaked at $304M in Q2 2015.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Ameriprise's 13F filing for Q1 2017, filed 5 May 2017.